- The trend backdrop is active with a 10-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
A58
GER
Week ended 07 Aug 2026
Weekly Investor Report
Elevance Health, Inc. · Healthcare · Healthcare Plans
Latest close
339.6 EUR
3.2%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 13.1% above the Trend Line and sits at 54.9% of its 52-week range. The latest completed week returned 3.2%, after a -7.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 48/100. Near-term considerations: volume confirmation is below normal.
Setup score
38
out of 100
Latest Close
339.6 EUR
7 Aug 2026
1W Return
3.2%
latest completed week
4W Return
-7.7%
short-term follow-through
12W Return
25.5%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 24.83% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.2%
Latest completed week; four-week move -7.7%.
Indicator stack
45/56
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 24.83%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
48/100
13 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.1% above the Trend Line and sits at 54.9% of its 52-week range. The latest completed week returned 3.2%, after a -7.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6912-week average 0.42
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.69Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.7% over four weeks, 25.5% over 12 weeks, and -19.6% over one year. The current trend has remained active for 10 consecutive weeks.
Performance by holding period
Active trend streak10 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.56Latest activity-pressure read.
Pressure change-47.7%Four-week change in activity pressure.
Leadership-3.73Latest relative-leadership reading.
RS change-155.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 85%
Model confidence 79%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength49/100Blend of value, momentum, and quality. Underlying universe rank 52; rank 1 is best.
Value76/100Relative valuation strength. Underlying universe rank 25; rank 1 is best.
Quality25/100Profitability and accounting quality. Underlying universe rank 76; rank 1 is best.
Momentum19/100Medium-term price momentum. Underlying universe rank 82; rank 1 is best.
Growth67/100Revenue and earnings growth. Underlying universe rank 34; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 14.0x Price divided by trailing earnings.
- Price / sales
- 0.4x Market value relative to trailing revenue.
- EV / EBITDA
- 10.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 6.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- 3.8% Operating profit retained from revenue.
- Free-cash-flow margin
- 3.2% Free cash flow generated from revenue.
- Return on invested capital
- 8.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 12.6% Latest one-year revenue growth.
- EPS growth
- -2.4% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -30.3% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.3% Cash dividends relative to market value.
- Buyback yield
- 3.8% Net share repurchases relative to market value.
- Shareholder yield
- 5.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 13 relevant articles.
1 positive · 9 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-19.6%Distance below the 52-week high.
13-week volatility8.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2610 weeks finished lower.
Best week+25.1%Week of 22 May.
Worst week-12.6%Week of 17 Jul.
Latest week+3.2%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains6
Flat weeks4
Modest losses7
Sharp losses3
Recent vol8.2%13-week weekly-return volatility.
Base vol7.3%52-week weekly-return volatility.
Up/down split18/18Count of positive and negative weeks in the 52-week window.
Average skew5.2% / -5.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Healthcare
4-week rank68 / 78
Group average1.4%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD69.2%positive activity pressure
RS34.6%positive relative leadership
Four-week leaders
IndustryDE Healthcare Plans
4-week rank2 / 3
Group average-7.6%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape37/100
Trend, activity pressure, participation, and risk combine to a 37/100 tape read.
Indicator analysis69/100Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 4/12.
Activity pressure 0.69; No reversal markers Next-Week ExpectancyNegative 24.83%Next-week expectancy is negative with a 24.83% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors41/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 11; Small Cap Core rank 27 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 13 relevant articles.
Oscar Health, Inc. (OSCR) stock price, news, quote and history Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 339.6 EUR | 3.2% | 300.4 EUR | 389.6 EUR | 0.56 | -3.73 | 9 | On |
| 31 Jul 2026 | 329.2 EUR | -0.6% | 299.6 EUR | 390.1 EUR | 0.79 | -4.79 | 96 | On |
| 24 Jul 2026 | 331.3 EUR | 3.0% | 298.7 EUR | 390.7 EUR | 0.91 | -2.88 | 33 | On |
| 17 Jul 2026 | 321.8 EUR | -12.6% | 297.2 EUR | 391.2 EUR | 1.02 | -5.21 | 201 | On |
| 10 Jul 2026 | 368.1 EUR | 0.3% | 296.2 EUR | 391.6 EUR | 1.08 | 6.74 | 14 | On |
| 3 Jul 2026 | 367.1 EUR | 6.9% | 294.0 EUR | 391.6 EUR | 1.04 | 3.12 | 0 | On |
| 26 Jun 2026 | 343.4 EUR | 1.4% | 291.1 EUR | 391.7 EUR | 1.06 | 0.30 | 15 | On |
| 19 Jun 2026 | 338.5 EUR | -1.8% | 289.3 EUR | 392.1 EUR | 1.06 | -2.87 | 0 | On |
| 12 Jun 2026 | 344.6 EUR | -3.6% | 287.1 EUR | 392.5 EUR | 1.06 | -0.34 | 0 | On |
| 5 Jun 2026 | 357.3 EUR | 7.3% | 284.8 EUR | 392.8 EUR | 0.92 | 2.26 | 54 | On |
| 29 May 2026 | 333.0 EUR | -1.6% | 281.7 EUR | 393.2 EUR | 0.74 | -6.37 | 0 | Off |
| 22 May 2026 | 338.6 EUR | 25.1% | 284.7 EUR | 393.7 EUR | 0.57 | -4.54 | 8 | Off |
| 15 May 2026 | 270.6 EUR | 0.0% | 287.5 EUR | 394.2 EUR | 0.37 | -21.17 | 0 | Off |
| 8 May 2026 | 270.6 EUR | 0.0% | 292.6 EUR | 395.1 EUR | 0.26 | -23.10 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.